The Journal of Pediatrics
Volume 149, Issue 2 , Pages 237-240 , August 2006

Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease

  • Kimiyasu Egami, MD

      Affiliations

    • Department of Pediatrics, Kurume University, Kurume, Japan
    • ,
  • Hiromi Muta, MD

      Affiliations

    • Department of Pediatrics, Kurume University, Kurume, Japan
    • Corresponding Author InformationReprint requests: Hiromi Muta, MD, 67 Asahi-machi, Kurume, 830-0011, Japan.
    • ,
  • Masahiro Ishii, MD

      Affiliations

    • Department of Pediatrics, Kitasato University, Sagamihara, Japan
    • ,
  • Kenji Suda, MD

      Affiliations

    • Department of Pediatrics, Kurume University, Kurume, Japan
    • ,
  • Yoko Sugahara, MD

      Affiliations

    • Department of Pediatrics, Kurume University, Kurume, Japan
    • ,
  • Motofumi Iemura, MD

      Affiliations

    • Department of Pediatrics, Kurume University, Kurume, Japan
    • ,
  • Toyojiro Matsuishi, MD

      Affiliations

    • Department of Pediatrics, Kurume University, Kurume, Japan

Received 10 August 2005 ,Revised 23 February 2006 ,Accepted 31 March 2006.

References 

  1. Newburger JW , Takahashi M , Burns JC , Beiser AS , Chung KJ , Duffy CE , et al.   The treatment of Kawasaki syndrome with intravenous gamma globulin . N Engl J Med . 1986;315:341–347
  2. Newburger JW , Takahashi M , Beiser AS , Burns JC , Bastian J , Chung KJ , et al.   A single intravenous infusion of gamma-globulin as compared with four infusions in the treatment of acute Kawasaki syndrome . N Engl J Med . 1991;324:1633–1639
  3. Sato N , Sugimura T , Akagi T , Yamakawa R , Hashino K , Eto G , et al.   Selective high dose gamma-globulin treatment in Kawasaki disease (assessment of clinical aspects and cost effectiveness) . Pediatr Int . 1999;41:1–7
  4. Sundel RP , Burns JC , Baker A , Beiser AS , Newburger JW . Gamma globulin re-treatment in Kawasaki disease . J Pediatr . 1993;123:657–659
  5. Burns JC , Capparelli EV , Brown JA , Newburger JW , Glode MP . Intravenous gamma-globulin treatment and retreatment in Kawasaki disease . Pediatr Infect Dis J . 1998;17:1144–1148
  6. Han RK , Silverman ED , Newman A , McCrindle BW . Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease . Arch Pediatr Adolesc Med . 2000;154:694–699
  7. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000;105(6):E78. Available at: http://www.pediatrics.org/cgi/content/full/105/6/e78.
  8. Fukunishi M , Kikkawa M , Hamana K , Onodera T , Matsuzaki K , Matumoto Y . Prediction of non-response to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset . J Pediatr . 2000;137:172–176
  9. Durongpisitkul K , Soongswang J , Laohaprasitiporn D , Nana A , Prachuabmoh C , Kangkagate C . Immunoglobulin failure and retreatment in Kawasaki disease . Pediatr Cardiol . 2003;24:145–148
  10. Hsieh K , Weng K , Lin C , Huang T , Lee C , Huang S . Treatment of acute Kawasaki disease (aspirin’s role in the febrile stage revisited) . Pediatrics . 2004;114:e689–e693 Available at: URL: http://www.pediatrics.org/cgi/doi/10.1542/peds.2004-1037.
  11. The Japan Kawasaki disease research committee . Diagnostic guidelines of Kawasaki disease . 5th revised ed.. 2002; Available at: http://www.kawasaki-disease.org/diagnostic/index.html.
  12. Research Committee on Kawasaki disease . Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease . Tokyo, Japan: Ministry of Health and Welfare; 1994;
  13. Muta H , Ishii M , Hirose A , Furui J , Sugahara Y , Himeno W , et al.   Randomized prospective controlled study of intravenous gamma-globulin products in treatment of Kawasaki disease . [in Japanese] J Jpn Soc Pediatr . 2002;106:742–746
  14. Moran AM , Newburger JW , Sanders SP , Parness IA , Spevak PJ , Burns JC , et al.   Abnormal myocardial mechanics in Kawasaki disease (rapid response to gamma-globulin) . Am Heart J . 2000;139:217–223
  15. Hashino K , Ishii M , Iemura M , Akagi T , Kato H . Re-treatment for immune globulin-resistant Kawasaki disease (a comparative study of additional immune globulin and steroid pulse therapy) . Pediatr Int . 2001;43:211–217
  16. Metz CE . Basic principles of ROC analysis . Semin Nucl Med . 1978;8:283–298
  17. Cantor SB , Sun CC , Tortolero-Luna G , Richards-Kortum R , Follen M . A comparison of C/B ratios from studies using receiver operating characteristics curve analysis . J Clin Epidemiol . 1999;52:885–892
  18. Muta H , Ishii M , Egami K , Furui J , Sugahara Y , Akagi T , et al.   Early intravenous gamma-globulin treatment for Kawasaki disease (the nationwide surveys in Japan) . J Pediatr . 2004;144:496–499
  19. Niwa K , Aotsuka H , Hamada H , Uchishiba M , Terai M , Niimi H . Thrombocytopenia (a risk factor for acute myocardial infarction during the acute phase of Kawasaki disease) . Coron Artery Dis . 1995;6:857–864
  20. Furukawa S , Matsubara T , Yabuta K . Kawasaki disease (immunological review, and case reports of familial Kawasaki disease and complicated by DIC) . [in Japanese] Riumachi-ka . 1993;9:165–174
  21. Rosenfeld EA , Corydon KE , Shulman ST . Kawasaki disease in infant less than one year of age . J Pediatr . 1995;126:524–529
  22. Harada K . Intravenous gamma-globulin treatment in Kawasaki disease . Acta Paediatr Jpn . 1991;33:805–810
  23. Wright DA , Newburger JW , Baker A , Sundel RP . Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids . J Pediatr . 1996;128:146–149
  24. Imanaga T , Mori M , Miyamae T , Ito S , Nakamura T , Yasui K , et al.   Plasma exchange for refractory Kawasaki disease . Eur J Pediatr . 2004;163:263–264
  25. Burns JC , Mason WH , Hauger SB , Janai H , Bastian JF , Wohrley JD , et al.   Infliximab treatment for refractory Kawasaki syndrome . J Pediatr . 2005;146:662–667
  26. Shinohara M , Sone K , Tomomasa T , Morikawa A . Corticosteroids in the treatment of the acute phase of Kawasaki disease . J Pediatr . 1999;135:465–469
  27. Sundel RP , Baker AL , Fulton DR , Newburger JW . Corticosteroids in the initial treatment of Kawasaki disease (report of a randomized trial) . J Pediatr . 2003;142:611–616
  28. de Zorzi A , Coran SD , Gauvreau K , Baker AL , Sundel R , Newburger JW . Coronary artery dimensions may be misclassified as normal in Kawasaki disease . J Pediatr . 1998;133:254–258

 This work is supported in part by Kawasaki Disease Research Committee and “Academic Frontier” Project, The Ministry of Education, Culture, Sports, Science, and Technology, Japan.

PII: S0022-3476(06)00272-1

doi: 10.1016/j.jpeds.2006.03.050

The Journal of Pediatrics
Volume 149, Issue 2 , Pages 237-240 , August 2006

Article Tools

* Image Usage & Resolution